希拉季特和马马贾卡对2型糖尿病奈米提卡·拉萨亚纳效应 的临床研究
A clinical study on the Naimittika Rasayana effect of Silajatu and Mamajjaka in type-2 Diabetes Mellitus.
作者信息
Kumar Sanjai, Singh Girish, Pandey Ajai Kumar, Singh Ram Harsh
机构信息
Department of Kayachikitsa, Faculty of Ayurveda, Banaras Hindu University, Varanasi, India.
Division of Biostatistics, Department of Community Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
出版信息
Ayu. 2014 Oct-Dec;35(4):404-10. doi: 10.4103/0974-8520.159000.
BACKGROUND
Recent years have shown an alarming rise in the incidence of diabetes mellitus (DM) all over the world. The present management of DM it not satisfactory. Hence, alternative systems of medicine are also being explored. Prameha as described in Ayurveda is a disease synonymous with today's DM. The patients of Prameha inherently carry the risk of impaired Agni and depleted Ojas status, that is, hypometabolic and immuno-compromised state. Now the primary goal is not merely to achieve normoglycemia, but also to minimize its complications. In this context, many Ayurvedic drugs are undergoing extensive research.
AIM
To evaluate the anti-diabetic, immune-enhancer and biofire balancing effects of Naimittika Rasayana drugs viz. Silajatu and Mamajjaka in type-2 DM.
MATERIALS AND METHODS
A total of 95 patients of type-2 DM were registered; in which 84 patients turned up for full follow-up. Patients were randomly allocated into three groups; Group-A was treated with Mamajjaka (500mg twice a day) and Group-B with Silajatu (500mg twice a day) and Group-C was treated with modern drug and assessment was done at monthly intervals for three months.
RESULTS
The selected Rasayana drugs have shown good response on subjective and objective parameters. The Mamajjaka treated patients responded better. However, as regards the reduction of post prandial blood sugar, Silajatu was superior.
CONCLUSION
The Ayurveda-inspired holistic approach seems to have a unique response promoting Agni (biofire) and Ojas (immune strength) status leading to good health and wellness.
背景
近年来，全球糖尿病（DM）发病率呈惊人的上升趋势。目前糖尿病的治疗并不令人满意。因此，人们也在探索替代医学体系。阿育吠陀中描述的“普拉密哈”是一种与当今糖尿病同义的疾病。普拉密哈患者天生就有胃火受损和精气耗竭的风险，即代谢减退和免疫功能低下状态。现在的主要目标不仅是实现血糖正常，还要尽量减少其并发症。在这种背景下，许多阿育吠陀药物正在进行广泛研究。
目的
评估偶发性滋补药西拉杰图和马马贾卡对2型糖尿病的抗糖尿病、免疫增强和生物火平衡作用。
材料与方法
共登记95例2型糖尿病患者；其中84例患者前来进行全程随访。患者被随机分为三组；A组用马马贾卡治疗（每日两次，每次500毫克），B组用西拉杰图治疗（每日两次，每次500毫克），C组用现代药物治疗，并连续三个月每月进行评估。
结果
所选的滋补药在主观和客观参数上均显示出良好的反应。用马马贾卡治疗的患者反应更好。然而，在降低餐后血糖方面，西拉杰图更具优势。
结论
受阿育吠陀启发的整体方法似乎具有独特的反应，可促进胃火（生物火）和精气（免疫力量）状态，从而带来健康和 wellness。 （此处“wellness”直接保留英文，因为在医学语境中有时会保留特定英文术语不翻译，以保持专业性和准确性）
Zotero 插件